Benjamin L. Walter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Benjamin L. Walter has a total of 534 co-authors. Here are the top co-authors by number of shared publications:
Alexander Meining
Gastroenterology, University of Ulm, Ulm, Germany
7 shared publications- Martin Müller
Department of Internal Medicine I, Ulm University Hospital, 89081 Ulm, Germany
7 shared publications - Robert F. Kirsch
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA
7 shared publications - William D. Memberg
Case Western Reserve University
7 shared publications - Anson. B. Rosenfeldt
Cleveland Clinic, Department of Biomedical Engineering, 9500 Euclid Ave., Cleveland, OH, USA
6 shared publications - Jay L. Alberts
Department of Biomedical Engineering, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA
6 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Wiley in Annals of Neurology
- Vol. 100 (5) , 1068-1079
Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease
Objective: Hospitalized people with Parkinson's disease (PwP) face increased risks of medication errors and discharge to non‐home settings, both of which are associated with adverse outcomes. This study assessed differences in medication error rates and discharge outcomes before and after implementation of a dedicated inpatient program for hospitalized PwP. Methods: During 2023, a Parkinson's disease (PD) inpatient program was implemented and refined combining: (1) an electronic health record (EHR) census for identification of hospitalized PwP; (2) inpatient monitoring and alignment of inpatient and outpatient regimens by movement‐disorders‐trained advanced practitioners; (3) customized EHR alerts and levodopa orders; (4) pharmacist support, and (5) staff education. Medication error rates and clinical outcomes were compared between January and June 2024 (post‐implementation phase) and a pre‐implementation retrospective cohort from 2018. Results: From January to June 2024, 366 post‐implementation admissions were monitored. Among those receiving contraindicated medications, the median number of doses decreased from 2 (interquartile range [IQR] = 1–6) during pre‐implementation to 1 (IQR: 1–2) post‐implementation ( p = 0.015). Days with a levodopa dose deviation decreased from 43.1% to 38.3%, p < 0.0001, improper levodopa formulation substitutions from 18.6% to 5%, p < 0.0001, timing deviations from 72.2% to 51.8%, p < 0.00001, missed doses from 21.5% to 16.8%, p = 0.013, and discharged to non‐home settings from 44.8% to 38.3%, p = 0.038. Interpretation: Following implementation of a multidisciplinary and proactive inpatient program, reductions in medication errors and improved discharge outcomes were observed among PwP. ANN NEUROL 2026;100:1068–1079
- 31 August 2026
- Published by Wiley in Annals of Neurology
- Vol. 100 (5) , 1068-1079
Open AccessEffects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease
Objective: Hospitalized people with Parkinson's disease (PwP) face increased risks of medication errors and discharge to non‐home settings, both of which are associated with adverse outcomes. This study assessed differences in medication error rates and discharge outcomes before and after implementation of a dedicated inpatient program for hospitalized PwP. Methods: During 2023, a Parkinson's disease (PD) inpatient program was implemented and refined combining: (1) an electronic health record (EHR) census for identification of hospitalized PwP; (2) inpatient monitoring and alignment of inpatient and outpatient regimens by movement‐disorders‐trained advanced practitioners; (3) customized EHR alerts and levodopa orders; (4) pharmacist support, and (5) staff education. Medication error rates and clinical outcomes were compared between January and June 2024 (post‐implementation phase) and a pre‐implementation retrospective cohort from 2018. Results: From January to June 2024, 366 post‐implementation admissions were monitored. Among those receiving contraindicated medications, the median number of doses decreased from 2 (interquartile range [IQR] = 1–6) during pre‐implementation to 1 (IQR: 1–2) post‐implementation ( p = 0.015). Days with a levodopa dose deviation decreased from 43.1% to 38.3%, p < 0.0001, improper levodopa formulation substitutions from 18.6% to 5%, p < 0.0001, timing deviations from 72.2% to 51.8%, p < 0.00001, missed doses from 21.5% to 16.8%, p = 0.013, and discharged to non‐home settings from 44.8% to 38.3%, p = 0.038. Interpretation: Following implementation of a multidisciplinary and proactive inpatient program, reductions in medication errors and improved discharge outcomes were observed among PwP. ANN NEUROL 2026;100:1068–1079
- Open Access
Utilizing an Augmented Reality Headset to Accurately Quantify Lower Extremity Function in Parkinson’s Disease
Subjective, imprecise evaluation of lower extremity function hinders the effective treatment of gait impairments in Parkinson’s disease (PD). Markerless motion capture (MMC) offers opportunities for integrating objective biomechanical outcomes into clinical practice. However, validation of MMC biomechanical outcomes is necessary for clinical adoption of MMC technologies. This project evaluated the criterion validity of a custom MMC algorithm (CART-MMC) against gold-standard 3D motion capture (Traditional-MC) and its known-groups validity in differentiating PD from healthy controls (HC). Sixty-two individuals with PD and 29 HCs completed a stepping in place paradigm. The trials were recorded by an augmented reality headset with embedded RGB and depth cameras. The CART-MMC algorithm was used to reconstruct a 3D pose model and compute biomechanical measures of lower extremity performance. CART-MMC outcomes were statistically equivalent, within 5% of Traditional-MC, for measures of step count, cadence, duration, height, height asymmetry, and normalized path length. CART-MMC captured significant between-group differences in step height, height variability, height asymmetry, duration variability, and normalized path length. In conclusion, CART-MMC provides valid biomechanical outcomes that characterize important domains of PD lower extremity function. Validated biomechanical evaluation tools present opportunities for tracking subtle changes in disease progression, informing targeted therapy, and monitoring treatment efficacy.
Open AccessUtilizing an Augmented Reality Headset to Accurately Quantify Lower Extremity Function in Parkinson’s Disease
Subjective, imprecise evaluation of lower extremity function hinders the effective treatment of gait impairments in Parkinson’s disease (PD). Markerless motion capture (MMC) offers opportunities for integrating objective biomechanical outcomes into clinical practice. However, validation of MMC biomechanical outcomes is necessary for clinical adoption of MMC technologies. This project evaluated the criterion validity of a custom MMC algorithm (CART-MMC) against gold-standard 3D motion capture (Traditional-MC) and its known-groups validity in differentiating PD from healthy controls (HC). Sixty-two individuals with PD and 29 HCs completed a stepping in place paradigm. The trials were recorded by an augmented reality headset with embedded RGB and depth cameras. The CART-MMC algorithm was used to reconstruct a 3D pose model and compute biomechanical measures of lower extremity performance. CART-MMC outcomes were statistically equivalent, within 5% of Traditional-MC, for measures of step count, cadence, duration, height, height asymmetry, and normalized path length. CART-MMC captured significant between-group differences in step height, height variability, height asymmetry, duration variability, and normalized path length. In conclusion, CART-MMC provides valid biomechanical outcomes that characterize important domains of PD lower extremity function. Validated biomechanical evaluation tools present opportunities for tracking subtle changes in disease progression, informing targeted therapy, and monitoring treatment efficacy.
- Open Access
- 9 February 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (7) , 1-8
Data-driven neurobiological subtyping of Parkinson’s disease using diffusion MRI-derived isotropic diffusion
Purpose: Parkinson’s disease (PD) exhibits marked clinical and biological heterogeneity. This study aimed to identify neurobiologically defined PD subtypes using isotropic diffusion (ISO), a diffusion MRI-derived metric sensitive to changes in isotropic water diffusion associated with microstructural alterations, and to determine whether these subtypes differ in baseline motor profiles and longitudinal change in imaging and motor scores. Methods: Baseline ISO values were extracted from 12 subcortical motor regions in 156 de novo PD patients from the Parkinson’s Progression Markers Initiative. Hierarchical clustering was applied to ISO values to derive data-driven subtypes. Baseline differences in motor severity were assessed using independent two-sample t-tests. Longitudinal change in ISO and motor outcomes over four years was evaluated using baseline-adjusted change-score regression models in patients with complete follow-up data ( n = 78). Results: Two subtypes emerged: subtype 1 ( n = 62) with lower ISO values and subtype 2 ( n = 94) with higher ISO across all regions. Subtype 2 showed greater baseline rigidity and bradykinesia. In longitudinal analyses (subtype 1, n = 34; subtype 2, n = 44), no significant differences were observed between subtypes in change in ISO across subcortical regions or in progression of motor scores over four years. Conclusion: Our findings indicate that ISO-derived subtypes are associated with distinct baseline neurobiological and motor profiles in early PD, but do not show evidence of differential motor or imaging progression over a four-year follow-up. This pattern highlights the complexity of PD heterogeneity and underscores the need for further investigation in larger, long-term cohorts.
- 9 February 2026
- Published by Springer Nature in Neuroradiology
- Vol. 68 (7) , 1-8
Open AccessData-driven neurobiological subtyping of Parkinson’s disease using diffusion MRI-derived isotropic diffusion
Purpose: Parkinson’s disease (PD) exhibits marked clinical and biological heterogeneity. This study aimed to identify neurobiologically defined PD subtypes using isotropic diffusion (ISO), a diffusion MRI-derived metric sensitive to changes in isotropic water diffusion associated with microstructural alterations, and to determine whether these subtypes differ in baseline motor profiles and longitudinal change in imaging and motor scores. Methods: Baseline ISO values were extracted from 12 subcortical motor regions in 156 de novo PD patients from the Parkinson’s Progression Markers Initiative. Hierarchical clustering was applied to ISO values to derive data-driven subtypes. Baseline differences in motor severity were assessed using independent two-sample t-tests. Longitudinal change in ISO and motor outcomes over four years was evaluated using baseline-adjusted change-score regression models in patients with complete follow-up data ( n = 78). Results: Two subtypes emerged: subtype 1 ( n = 62) with lower ISO values and subtype 2 ( n = 94) with higher ISO across all regions. Subtype 2 showed greater baseline rigidity and bradykinesia. In longitudinal analyses (subtype 1, n = 34; subtype 2, n = 44), no significant differences were observed between subtypes in change in ISO across subcortical regions or in progression of motor scores over four years. Conclusion: Our findings indicate that ISO-derived subtypes are associated with distinct baseline neurobiological and motor profiles in early PD, but do not show evidence of differential motor or imaging progression over a four-year follow-up. This pattern highlights the complexity of PD heterogeneity and underscores the need for further investigation in larger, long-term cohorts.
- Open Access
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1) , 6998888
Using Loss of Balance to Understand Postural Instability Associated With Parkinson’s Disease
Background/Objectives: Postural instability compromises balance, contributing to annual fall rates of 45%–68% in Parkinson’s disease (PD). A fundamental gap in clinical evaluation and treatment of postural instability is the use of insufficiently challenging postural control tests and reliance on subjective scoring. Traditional 3D motion capture (Traditional‐MC), while precise and objective, is not feasible for clinical utilization. Markerless motion capture (MMC) is a viable candidate for quantifying postural control, feasible with embedded cameras of augmented reality (AR) headsets. This project aimed to assess MMC accuracy in quantifying postural control and to compare PD patients and healthy controls (HCs) to develop a loss‐of‐balance (LOB) prediction model. Methods: Video data were acquired by a clinician wearing a Microsoft HoloLens 2 AR headset as participants completed three progressively challenging postural control stances. Depth and red–green–blue camera data were analyzed with our custom‐built human pose estimation software (CART‐MMC). Criterion validity between Traditional‐MC and CART‐MMC was completed on outcomes, 95% ellipsoid sway area (Sway area) and 95% mediolateral and anteroposterior (ML and AP) ranges in 54 (HC = 28, PD = 26) participants. Group differences were assessed, and survival analysis was conducted to quantify no LOB probabilities in 31 HCs and 68 PD patients. A relaxed LASSO model was used to predict LOB in the PD group from CART‐MMC data. Results: Sway area and ML range from CART‐MMC were equivalent to Traditional‐MC. Furthermore, ML range from CART‐MMC differentiated PD patients from HCs in the stance that had the highest completion rate. As postural task difficulty increased, fewer PD patients were able to complete compared to HCs, resulting in lower survival probabilities of the PD group in Tandem‐Firm‐EO and FT‐Foam‐EC stances. In the least challenging stance, ML range predicted the occurrence of LOB in the more challenging stance (LOO‐CV AUC = 0.78). Conclusions: CART‐MMC is a valid method of obtaining objective postural control outcomes, which can detect latent postural control deficits and demonstrates a scalable, objective clinical and remote monitoring approach for predicting falls.
- 1 January 2026
- Published by Wiley in Parkinson's Disease
- Vol. 2026 (1) , 6998888
Open AccessUsing Loss of Balance to Understand Postural Instability Associated With Parkinson’s Disease
Background/Objectives: Postural instability compromises balance, contributing to annual fall rates of 45%–68% in Parkinson’s disease (PD). A fundamental gap in clinical evaluation and treatment of postural instability is the use of insufficiently challenging postural control tests and reliance on subjective scoring. Traditional 3D motion capture (Traditional‐MC), while precise and objective, is not feasible for clinical utilization. Markerless motion capture (MMC) is a viable candidate for quantifying postural control, feasible with embedded cameras of augmented reality (AR) headsets. This project aimed to assess MMC accuracy in quantifying postural control and to compare PD patients and healthy controls (HCs) to develop a loss‐of‐balance (LOB) prediction model. Methods: Video data were acquired by a clinician wearing a Microsoft HoloLens 2 AR headset as participants completed three progressively challenging postural control stances. Depth and red–green–blue camera data were analyzed with our custom‐built human pose estimation software (CART‐MMC). Criterion validity between Traditional‐MC and CART‐MMC was completed on outcomes, 95% ellipsoid sway area (Sway area) and 95% mediolateral and anteroposterior (ML and AP) ranges in 54 (HC = 28, PD = 26) participants. Group differences were assessed, and survival analysis was conducted to quantify no LOB probabilities in 31 HCs and 68 PD patients. A relaxed LASSO model was used to predict LOB in the PD group from CART‐MMC data. Results: Sway area and ML range from CART‐MMC were equivalent to Traditional‐MC. Furthermore, ML range from CART‐MMC differentiated PD patients from HCs in the stance that had the highest completion rate. As postural task difficulty increased, fewer PD patients were able to complete compared to HCs, resulting in lower survival probabilities of the PD group in Tandem‐Firm‐EO and FT‐Foam‐EC stances. In the least challenging stance, ML range predicted the occurrence of LOB in the more challenging stance (LOO‐CV AUC = 0.78). Conclusions: CART‐MMC is a valid method of obtaining objective postural control outcomes, which can detect latent postural control deficits and demonstrates a scalable, objective clinical and remote monitoring approach for predicting falls.
- Open Access
- 3 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Crew resource management and threat and error management improve team communication in endoscopy: a prospective study
In gastrointestinal endoscopy, the ability to perform increasingly complex procedures has significantly heightened the demand for effective team cooperation. Crew Resource Management (CRM) and Threat and Error Management (TEM), proven strategies from civil aviation, have the potential to enhance team communication, workflow and patient outcomes in complex medical settings such as interventional endoscopy and therefore were implemented into endoscopy unit in this study. Together with qualified CRM trainers, individually tailored CRM and TEM elements such as communication guidelines, checklists and TEM-based dialogic team-time-outs were developed with the employees and integrated into endoscopic workflow at a high-volume interventional endoscopy center. Employee surveys on the effects were performed before and after the implementation. Implementation of CRM and TEM elements into endoscopy with civil aviation experts improved team communication, workflow and teamwork in endoscopy. Our study found a significantly reduced rate of misunderstandings caused by ambiguous communication during endoscopic interventions ( p = 0.034), a significantly clearer defined distribution of tasks during the procedure ( p = 0.020) and a significantly improved physicians’ information transfer to the nursing assistants before the procedure ( p = 0.047). More than 80% of all employees perceived that patient safety had improved after the intervention.
- 3 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessCrew resource management and threat and error management improve team communication in endoscopy: a prospective study
In gastrointestinal endoscopy, the ability to perform increasingly complex procedures has significantly heightened the demand for effective team cooperation. Crew Resource Management (CRM) and Threat and Error Management (TEM), proven strategies from civil aviation, have the potential to enhance team communication, workflow and patient outcomes in complex medical settings such as interventional endoscopy and therefore were implemented into endoscopy unit in this study. Together with qualified CRM trainers, individually tailored CRM and TEM elements such as communication guidelines, checklists and TEM-based dialogic team-time-outs were developed with the employees and integrated into endoscopic workflow at a high-volume interventional endoscopy center. Employee surveys on the effects were performed before and after the implementation. Implementation of CRM and TEM elements into endoscopy with civil aviation experts improved team communication, workflow and teamwork in endoscopy. Our study found a significantly reduced rate of misunderstandings caused by ambiguous communication during endoscopic interventions ( p = 0.034), a significantly clearer defined distribution of tasks during the procedure ( p = 0.020) and a significantly improved physicians’ information transfer to the nursing assistants before the procedure ( p = 0.047). More than 80% of all employees perceived that patient safety had improved after the intervention.
- Open Access
- 29 October 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e77720
Improving Recruitment Into Research Studies via Electronically Collected Patient-Entered Data: Mixed Methods Study
Background: Patient recruitment remains a critical challenge in clinical research. Although the integration of electronically collected patient-entered data within clinical practices enables innovative recruitment approaches, existing methods present challenges such as increased patient burden and potential violation of autonomy. A more nuanced approach involves identifying patient attributes associated with higher propensity for research participation, enabling research teams to efficiently prioritize outreach efforts. Objective: This study aims to (1) develop patient-reported questions reflecting perceptions about research participation and (2) determine whether patient responses are predictive of interest in joining a precision medicine registry. Methods: This mixed methods study used an exploratory sequential design in 2 phases. Phase 1 involved cognitive interviews with 32 patients recruited through the Cleveland Clinic Healthcare Partners program to develop “research perception” questions. Participants evaluated 9 candidate questions that were based on a literature review of research participation factors. Three questions were selected for implementation. Phase 2 was a cross-sectional cohort study incorporating these 3 questions into routine electronic questionnaires completed by primary care patients through the patient portal. The study population included 1077 patients who completed both “research perception” and “research recruitment” questions between August 2018 and April 2019. Diagnostic accuracy was assessed using receiver operating characteristic curve analysis, and multivariable logistic regression models evaluated associations while adjusting for demographic and health factors. Results: Phase 1 revealed strong research support among participants, with 97% (31/32) agreeing that research should be part of the institution’s mission and 100% (32/32) affirming that research enhances patient care. Phase 2 included 1077 patients (mean age 48.3, SD 16.3 years; 625/1065 female, 58.68%; 661/1005 White, 65.77%), of whom 278 (25.8%) expressed interest in being contacted about the precision medicine registry. Patients expressing interest were older and had worse self-reported health, more depressive symptoms, and greater social needs. “Strongly agree” and “very important” responses to any “research perception” question were significantly associated with study interest, with adjusted odds ratios ranging from 6.36 (95% CI 2.77-14.6) to 17.6 (95% CI 5.08-61.1; P<.001). The “research perception” questions demonstrated high sensitivity (>80%) but limited specificity (24%-31%). Conclusions: Patient-reported questions assessing research participation likelihood can help identify patients more likely to enroll in clinical studies. This approach enables effective recruitment prioritization while preserving patient autonomy and reducing patient burden. High sensitivity makes these questions valuable as screening tools, although limited specificity suggests use for prioritizing rather than excluding participants. Further validation across different trial types and populations is warranted.
- 29 October 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e77720
Open AccessImproving Recruitment Into Research Studies via Electronically Collected Patient-Entered Data: Mixed Methods Study
Background: Patient recruitment remains a critical challenge in clinical research. Although the integration of electronically collected patient-entered data within clinical practices enables innovative recruitment approaches, existing methods present challenges such as increased patient burden and potential violation of autonomy. A more nuanced approach involves identifying patient attributes associated with higher propensity for research participation, enabling research teams to efficiently prioritize outreach efforts. Objective: This study aims to (1) develop patient-reported questions reflecting perceptions about research participation and (2) determine whether patient responses are predictive of interest in joining a precision medicine registry. Methods: This mixed methods study used an exploratory sequential design in 2 phases. Phase 1 involved cognitive interviews with 32 patients recruited through the Cleveland Clinic Healthcare Partners program to develop “research perception” questions. Participants evaluated 9 candidate questions that were based on a literature review of research participation factors. Three questions were selected for implementation. Phase 2 was a cross-sectional cohort study incorporating these 3 questions into routine electronic questionnaires completed by primary care patients through the patient portal. The study population included 1077 patients who completed both “research perception” and “research recruitment” questions between August 2018 and April 2019. Diagnostic accuracy was assessed using receiver operating characteristic curve analysis, and multivariable logistic regression models evaluated associations while adjusting for demographic and health factors. Results: Phase 1 revealed strong research support among participants, with 97% (31/32) agreeing that research should be part of the institution’s mission and 100% (32/32) affirming that research enhances patient care. Phase 2 included 1077 patients (mean age 48.3, SD 16.3 years; 625/1065 female, 58.68%; 661/1005 White, 65.77%), of whom 278 (25.8%) expressed interest in being contacted about the precision medicine registry. Patients expressing interest were older and had worse self-reported health, more depressive symptoms, and greater social needs. “Strongly agree” and “very important” responses to any “research perception” question were significantly associated with study interest, with adjusted odds ratios ranging from 6.36 (95% CI 2.77-14.6) to 17.6 (95% CI 5.08-61.1; P<.001). The “research perception” questions demonstrated high sensitivity (>80%) but limited specificity (24%-31%). Conclusions: Patient-reported questions assessing research participation likelihood can help identify patients more likely to enroll in clinical studies. This approach enables effective recruitment prioritization while preserving patient autonomy and reducing patient burden. High sensitivity makes these questions valuable as screening tools, although limited specificity suggests use for prioritizing rather than excluding participants. Further validation across different trial types and populations is warranted.
- Open Access
An Experimental Approach for Investigating Freezing of Gait in Parkinson’s Disease Using Virtual Reality and Neural Sensing: A Pilot Study
Freezing of gait (FOG) is a disabling symptom associated with Parkinson’s disease (PD). Its understanding and effective treatment is compromised due to the difficulty in reliably triggering FOG in clinical and laboratory environments. The Cleveland Clinic-Virtual Home Environment (CC-VHE) platform was developed to address the challenges of eliciting FOG by combining an omnidirectional treadmill with immersive virtual reality (VR) environments to induce FOG under physical, emotional, and cognitive triggers. Recent developments in deep brain stimulation devices that sense neural signals from the subthalamic nucleus in real time offer the potential to understand the underlying neural mechanism(s) of FOG. This manuscript presents the coupling of the CC-VHE technology, VR paradigms, and the experimental and analytical methods for recording and analyzing synchronous cortical, subcortical, and kinematic data as an approach to begin to understand the nuanced neural pathology associated with FOG. To evaluate the utility and feasibility of coupling VR and neural sensing technology, initial data from one participant are included.
Open AccessAn Experimental Approach for Investigating Freezing of Gait in Parkinson’s Disease Using Virtual Reality and Neural Sensing: A Pilot Study
Freezing of gait (FOG) is a disabling symptom associated with Parkinson’s disease (PD). Its understanding and effective treatment is compromised due to the difficulty in reliably triggering FOG in clinical and laboratory environments. The Cleveland Clinic-Virtual Home Environment (CC-VHE) platform was developed to address the challenges of eliciting FOG by combining an omnidirectional treadmill with immersive virtual reality (VR) environments to induce FOG under physical, emotional, and cognitive triggers. Recent developments in deep brain stimulation devices that sense neural signals from the subthalamic nucleus in real time offer the potential to understand the underlying neural mechanism(s) of FOG. This manuscript presents the coupling of the CC-VHE technology, VR paradigms, and the experimental and analytical methods for recording and analyzing synchronous cortical, subcortical, and kinematic data as an approach to begin to understand the nuanced neural pathology associated with FOG. To evaluate the utility and feasibility of coupling VR and neural sensing technology, initial data from one participant are included.
- Open Access
- 12 June 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 137, 107920
Including individuals with Parkinson's disease and deep brain stimulation in rehabilitation trials: feasibility, challenges, and preliminary gait and postural stability results
- 12 June 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 137, 107920
Open AccessIncluding individuals with Parkinson's disease and deep brain stimulation in rehabilitation trials: feasibility, challenges, and preliminary gait and postural stability results
- Open Access
- 4 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (11) , 3966
Validation of the Comprehensive Augmented Reality Testing Platform to Quantify Parkinson’s Disease Fine Motor Performance
Background/Objectives: Technological approaches for the objective, quantitative assessment of motor functions have the potential to improve the medical management of people with Parkinson’s disease (PwPD), offering more precise, data-driven insights to enhance diagnosis, monitoring, and treatment. Markerless motion capture (MMC) is a promising approach for the integration of biomechanical analysis into clinical practice. The aims of this project were to evaluate a commercially available MMC system, develop and validate a custom MMC data processing algorithm, and evaluate the effectiveness of the algorithm in discriminating fine motor performance between PwPD and healthy controls (HCs). Methods: A total of 58 PwPD and 25 HCs completed finger-tapping assessments, administered and recorded by a self-worn augmented reality headset. Fine motor performance was evaluated using the headset’s built-in hand tracking software (Native-MMC) and a custom algorithm (CART-MMC). Outcomes from each were compared against a gold-standard motion capture system (Traditional-MC) to determine the equivalence. Known-group validity was evaluated using CART-MMC. Results: A total of 82 trials were analyzed for equivalence against the Traditional-MC, and 152 trials were analyzed for known-group validity. The CART-MMC outcomes were statistically equivalent to Traditional-MC (within 5%) for tap count, frequency, amplitude, and opening velocity metrics. The Native-MMC did not meet equivalence with the Traditional-MC, deviating by an average of 24% across all outcomes. The CART-MMC captured significant differences between PwPD and HCs for tapping amplitude, amplitude variability, frequency variability, finger opening and closing velocities, and their respective variabilities, and normalized path length. Conclusions: The biomechanical data gathered using a commercially available augmented reality device and analyzed via a custom algorithm accurately characterize fine motor performance in PwPD.
- 4 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (11) , 3966
Open AccessValidation of the Comprehensive Augmented Reality Testing Platform to Quantify Parkinson’s Disease Fine Motor Performance
Background/Objectives: Technological approaches for the objective, quantitative assessment of motor functions have the potential to improve the medical management of people with Parkinson’s disease (PwPD), offering more precise, data-driven insights to enhance diagnosis, monitoring, and treatment. Markerless motion capture (MMC) is a promising approach for the integration of biomechanical analysis into clinical practice. The aims of this project were to evaluate a commercially available MMC system, develop and validate a custom MMC data processing algorithm, and evaluate the effectiveness of the algorithm in discriminating fine motor performance between PwPD and healthy controls (HCs). Methods: A total of 58 PwPD and 25 HCs completed finger-tapping assessments, administered and recorded by a self-worn augmented reality headset. Fine motor performance was evaluated using the headset’s built-in hand tracking software (Native-MMC) and a custom algorithm (CART-MMC). Outcomes from each were compared against a gold-standard motion capture system (Traditional-MC) to determine the equivalence. Known-group validity was evaluated using CART-MMC. Results: A total of 82 trials were analyzed for equivalence against the Traditional-MC, and 152 trials were analyzed for known-group validity. The CART-MMC outcomes were statistically equivalent to Traditional-MC (within 5%) for tap count, frequency, amplitude, and opening velocity metrics. The Native-MMC did not meet equivalence with the Traditional-MC, deviating by an average of 24% across all outcomes. The CART-MMC captured significant differences between PwPD and HCs for tapping amplitude, amplitude variability, frequency variability, finger opening and closing velocities, and their respective variabilities, and normalized path length. Conclusions: The biomechanical data gathered using a commercially available augmented reality device and analyzed via a custom algorithm accurately characterize fine motor performance in PwPD.